Full profile
| Also known as | Theanine, N-ethyl-L-glutamine |
|---|---|
| Best for | Calm focus · Taking the edge off caffeine · Settled attention during deep work |
| Evidence grade | Grade B · Moderate: several human trials, some mixed results |
| Studied dose range | 50–250 mg per serving across the trials cited here (Nobre 50 mg; Haskell 250 mg), most commonly 100–200 mg. |
| Time to effect | Often reported within 30–60 minutes; acute rather than cumulative. |
| Best form | Plain L-theanine. Suntheanine is a commonly referenced branded form. |
| Food sources | Green tea, Black tea |
Evidence, honestly graded
Held at B on 2026-09-14; with Bacopa, it is one of the two B-graded actives in the Signal State Core concept formula. A 2026 meta-analysis of 31 randomized trials (Gerolymos et al.) found a single 200 mg dose improved attention and reaction-time measures versus placebo (SMD 0.51); its acute-stress effect was smaller and leaned on higher-risk-of-bias studies, and it found no effect on fatigue. A 2025 meta-analysis of sleep trials (Bulman et al.) found better self-rated sleep quality and daytime functioning, but no change on objective sleep measures. What keeps it short of A: the attention signal shows up mainly on reaction-time tasks rather than as a broad, all-day calm-focus effect, most trials are small, several are industry-linked, and a smaller 2025 meta-analysis of five trials in 148 healthy adults (Mátyus et al.) splits: it found a dose-dependent improvement in rapid visual information processing and recognition reaction time (−15.20 ms), but no effect on simple reaction time or Stroop performance. Positive acute trials cluster in the 100–250 mg range; Health Canada's monograph permits a relaxation claim only, at 200–250 mg/day.
See the full grading rubric (study type, replication, population match, and dose adequacy) in The Evidence Standard.
What the benefits research does and doesn't support, in depth: L-Theanine Benefits: What the Research Actually Supports.
1,656 natural health products with an active licence in Health Canada's LNHPD list L-Theanine as a medicinal ingredient.
That makes L-Theanine a recognized, licensable medicinal ingredient in Canada, regulated by Health Canada's Natural and Non-prescription Health Products Directorate, which issues each licensed natural health product a Natural Product Number (NPN). Search the LNHPD to verify.
Side effects
- Generally well tolerated in studies
- Occasional reports of headache or lightheadedness
The full side-effect breakdown: L-Theanine Side Effects: What the Research Actually Shows.
Who should avoid it or check first
- Pregnant or breastfeeding without clinician guidance
- On blood-pressure medication without review
Interactions
- May interact with blood-pressure and stimulant medications; discuss with a clinician
Stacks well with
- Caffeine (classic calm-focus pairing)
- Citicoline
Use caution stacking with
- Sedatives without clinician guidance
What to look for on a label
- Look for a stated milligram dose per serving, not a proprietary blend.
- Branded forms should name the standardization on the label.
References
- Nobre AC, Rao A, Owen GN (2008). Asia Pacific Journal of Clinical Nutrition, 17(S1):167–168Increased alpha-band brain activity, a marker associated with relaxed alertness.
- Haskell CF, Kennedy DO, Milne AL, Wesnes KA, Scholey AB (2008). Biological Psychology, 77(2):113–122Theanine with caffeine improved reaction time and working memory; theanine alone increased subjective calm.
- Gerolymos C, Saddier E, Boyer L, Fond G (2026). Molecular PsychiatryA single 200 mg dose improved attention and reaction-time measures versus placebo (SMD 0.51, 95% CI 0.25–0.77); the acute-stress effect was smaller and driven by higher-risk-of-bias studies.
- Bulman A, D'Cunha NM, Marx W, et al. (2025). Sleep Medicine Reviews, 81Improved self-rated sleep quality (SMD 0.43), daytime dysfunction (SMD 0.33) and sleep-onset latency (SMD 0.15); no objective sleep measure changed significantly.
- Mátyus RO, Szikora Z, Bodó D, et al. (2025). Journal of Clinical Medicine, 14(21):7710A dose-dependent improvement in rapid visual information processing and recognition visual reaction time (−15.20 ms, 95% CI −28.99 to −1.41); no significant effect on simple reaction time or on the Stroop test.
- Payne ER, Aceves-Martins M, Dubost J, et al. (2025). Nutrition Reviews, 83(10):1873–1891Theanine alone favoured over placebo on choice reaction time one hour after intake (SMD −0.35, 95% CI −0.61 to −0.10); theanine plus caffeine showed small-to-moderate gains on several attention measures.
Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.
Revision history
Every change to this ingredient's evidence status, dated and explained. The full cross-library log lives at Evidence Updates.
- 2026-09-17Citation review
Corrected a one-sided description. This profile reported that the 2025 five-trial meta-analysis found no effect on simple reaction time or the Stroop test, which is true but leaves out that the same analysis found a dose-dependent improvement in rapid visual information processing and recognition reaction time. Both findings are now stated and the meta-analysis is cited in full, alongside a larger 2025 tea review whose Lipton and Unilever funding is disclosed. B holds.
- 2026-09-14Citation review
Held at B with two new meta-analyses added: a 2026 review of 31 RCTs found a single 200 mg dose improved attention and reaction time, and a 2025 review found improvements in self-rated, but not objectively measured, sleep.
- 2026-07-07New profile
Initial profile published at Grade B: multiple small human trials show acute calm and attention effects, often studied alongside caffeine, with modest and variable effect sizes.
See how L-Theanine compares on grade, dose, and goal in the Evidence Explorer.



